Related references
Note: Only part of the references are listed.Combining European and US risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study
Roxane de La Harpe et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)
Genetic and molecular architecture of familial hypercholesterolemia
Marianne Abifadel et al.
JOURNAL OF INTERNAL MEDICINE (2023)
Prevalence of metabolic syndrome in the United States National Health and Nutrition Examination Survey 2011-18
Xiaopeng Liang et al.
POSTGRADUATE MEDICAL JOURNAL (2023)
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
Gracia Fahed et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency
Cecilia Vitali et al.
JOURNAL OF LIPID RESEARCH (2022)
Apolipoproteins in vascular biology and atherosclerotic disease
Anurag Mehta et al.
NATURE REVIEWS CARDIOLOGY (2022)
Major adverse cardiovascular events in homozygous familial hypercholesterolaemia: a systematic review and meta-analysis
Adam Kramer et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)
Genetic Risk Assessment for Atherosclerotic Cardiovascular Disease: A Guide for the General Cardiologist
Matthew J. Belanger et al.
CARDIOLOGY IN REVIEW (2022)
Autosomal Recessive Hypercholesterolemia Caused by a Novel LDLRAP1 Variant and Membranous Nephropathy in a Chinese Girl: A Case Report
Siqin Feng et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Prediction of incident atherosclerotic cardiovascular disease with polygenic risk of metabolic disease: Analysis of 3 prospective cohort studies in Korea
Han Song et al.
ATHEROSCLEROSIS (2022)
Big Data Approaches for Prevention of the Metabolic Syndrome
Xinping Jiang et al.
FRONTIERS IN GENETICS (2022)
Pleiotropic Effects of APOB Variants on Lipid Profiles, Metabolic Syndrome, and the Risk of Diabetes Mellitus
Shih-Jung Jang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices
Nuntakorn Thongtang et al.
PREVENTIVE MEDICINE REPORTS (2022)
Genetics of Cholesterol-Related Genes in Metabolic Syndrome: A Review of Current Evidence
Sok Kuan Wong et al.
BIOMEDICINES (2022)
Searching for Better Biomarkers for Metabolic Syndrome
Jyoti Madhusoodanan
ACS CENTRAL SCIENCE (2022)
Monocyte to High-Density lipoprotein and Apolipoprotein A1 Ratios: Novel Indicators for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes
Wei Wang et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
A dominant negative ADIPOQ mutation in a diabetic family with renal disease, hypoadiponectinemia, and hyperceramidemia
Christopher A. Simeone et al.
NPJ GENOMIC MEDICINE (2022)
Association Between Familial Hypercholesterolemia and Risk of Cardiovascular Events and Death in Different Cohorts: A Meta-Analysis of 1.1 Million Subjects
Yani Yu et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
A Gene Variation at the ZPR1 Locus (rs964184) Interacts With the Type of Diet to Modulate Postprandial Triglycerides in Patients With Coronary Artery Disease: From the Coronary Diet Intervention With Olive Oil and Cardiovascular Prevention Study
Juan F. Alcala-Diaz et al.
FRONTIERS IN NUTRITION (2022)
Etiologic Puzzle of Coronary Artery Disease: How Important Is Genetic Component?
Lacramioara Ionela Butnariu et al.
LIFE-BASEL (2022)
Association between ApoA1 Gene, Plasma Lipid Profile, hsCRP Level, and Risk of Arterial Stiffness in Thai Elderly
Pruttaya Supajaree et al.
Advances in Preventive Medicine (2022)
Metabolic syndrome - a new definition and management guidelines
Piotr Dobrowolski et al.
ARCHIVES OF MEDICAL SCIENCE (2022)
Low-density lipoprotein receptor genotypes modify the sera metabolome of patients with homozygous familial hypercholesterolemia
Zhiyong Du et al.
ISCIENCE (2022)
Phenotypic Differences Among Familial Partial Lipodystrophy Due to LMNA or PPARG Variants
Chandna Vasandani et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2022)
Coronary Artery Disease Genetics Enlightened by Genome-Wide Association Studies
Thorsten Kessler et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)
Lipid and metabolic syndrome traits in coronary artery disease: a Mendelian randomization study
David G. Thomas et al.
JOURNAL OF LIPID RESEARCH (2021)
Recent advances in ABCG5 and ABCG8 variants
Vincent Fong et al.
CURRENT OPINION IN LIPIDOLOGY (2021)
The genetic counselor's role in management of patients with dyslipidemia
Emily E. Brown
CURRENT OPINION IN LIPIDOLOGY (2021)
Lipoprotein (a) and Hypertension
Natalie C. Ward et al.
CURRENT HYPERTENSION REPORTS (2021)
Lipoprotein metabolism in familial hypercholesterolemia
Kevin Chemello et al.
JOURNAL OF LIPID RESEARCH (2021)
A longitudinal study over 40 years to study the metabolic syndrome as a risk factor for cardiovascular diseases
Lars Lind et al.
SCIENTIFIC REPORTS (2021)
Prevalence of ApoB100 rs693 gene polymorphism in metabolic syndrome among female students at King Abdulaziz University
Rana A. Alghamdi et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2021)
miR-33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
Nathan L. Price et al.
EMBO MOLECULAR MEDICINE (2021)
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
Jennifer Behbodikhah et al.
METABOLITES (2021)
The impact of non-additive genetic associations on age-related complex diseases
Marta Guindo-Martinez et al.
NATURE COMMUNICATIONS (2021)
The relationship between metabolic syndrome and obstructive sleep apnea syndrome: a nationwide population-based study
Do Hyun Kim et al.
SCIENTIFIC REPORTS (2021)
High TG/HDL ratio suggests a higher risk of metabolic syndrome among an elderly Chinese population: a cross-sectional study
Guqiao Nie et al.
BMJ OPEN (2021)
The Genetic Basis of Hypertriglyceridemia
German D. Carrasquilla et al.
CURRENT ATHEROSCLEROSIS REPORTS (2021)
Lipoprotein Lipase Gene Polymorphisms Are Associated with Myocardial Infarction Risk: A Meta-Analysis
Kunhui He et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2021)
Current Diagnosis and Management of Tangier Disease
Masahiro Koseki et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2021)
Genetics of coronary artery disease in the post-GWAS era
Zhifen Chen et al.
JOURNAL OF INTERNAL MEDICINE (2021)
LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred
Roopa Mehta et al.
LIPIDS IN HEALTH AND DISEASE (2021)
Comparison of metabolic syndrome prevalence using four different definitions - a population-based study in Finland
Elsi Haverinen et al.
ARCHIVES OF PUBLIC HEALTH (2021)
A case of autosomal recessive hypercholesterolemia with a novel mutation in the LDLRAP1 gene
Parisa Nikasa et al.
CLINICAL PEDIATRIC ENDOCRINOLOGY (2021)
ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition
Yan Q. Chen et al.
JOURNAL OF LIPID RESEARCH (2021)
Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a mendelian randomisation analysis using outcomes in first-degree relatives
Tom G. Richardson et al.
LANCET HEALTHY LONGEVITY (2021)
Association of ADIPOQ rs266729 and rs1501299 gene polymorphisms and circulating adiponectin level with the risk of type 2 diabetes in a population of Iran: a case-control study
Mahrokh Alimi et al.
JOURNAL OF DIABETES AND METABOLIC DISORDERS (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)
Juhani Knuuti et al.
EUROPEAN HEART JOURNAL (2020)
Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases
Hyung Muk Choi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Gut microbiota and metabolic syndrome
Peng-Xu Wang et al.
CHINESE MEDICAL JOURNAL (2020)
Epigenetic regulation of insulin action and secretion - role in the pathogenesis of type 2 diabetes
C. Ling
JOURNAL OF INTERNAL MEDICINE (2020)
The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus
Sanabil Ali Hassan Ahmed et al.
CLINICAL EPIGENETICS (2020)
Genetics of Hypertriglyceridemia
Jacqueline S. Dron et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Apolipoprotein B Levels Predict Future Development of Hypertension Independent of Visceral Adiposity and Insulin Sensitivity
Seung Jin Han et al.
ENDOCRINOLOGY AND METABOLISM (2020)
Influence of multiple apolipoprotein A-I and B genetic variations on insulin resistance and metabolic syndrome in obstructive sleep apnea
Xinyi Li et al.
NUTRITION & METABOLISM (2020)
Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank
Amanda L. Lumsden et al.
EBIOMEDICINE (2020)
Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort
Maria J. Guembe et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Association of polymorphism genes LPL, ADRB2, AGT and AGTR1 with risk of hyperinsulinism and insulin resistance in the Kazakh population
Aizhan Shakhanova et al.
BIOMEDICAL REPORTS (2020)
The APOB rs693 polymorphism impacts the lipid profile of Brazilian older adults
E. S. Alves et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2020)
The association of the PCSK9 rs562556 polymorphism with serum lipids level: a meta-analysis
Junlan Chuan et al.
LIPIDS IN HEALTH AND DISEASE (2019)
Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategies
Eskandar Taghizadeh et al.
IUBMB LIFE (2019)
Apolipoprotein E gene polymorphism and the risk of cardiovascular disease and type 2 diabetes
Sudong Liu et al.
BMC CARDIOVASCULAR DISORDERS (2019)
Genome-Wide Association Study of the Metabolic Syndrome in UK Biobank
Lars Lind
METABOLIC SYNDROME AND RELATED DISORDERS (2019)
The role of adiponectin in cholesterol efflux and HDL biogenesis and metabolism
Anouar Hafiane et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
A genetic variant c.553G>T (rs2075291) in the apolipoprotein A5 gene is associated with altered triglycerides levels in coronary artery disease (CAD) patients with lipid lowering drug
Neda M. Bogari et al.
BMC CARDIOVASCULAR DISORDERS (2019)
Metabolic Messengers: adiponectin
Leon G. Straub et al.
NATURE METABOLISM (2019)
Associations between LPL gene polymorphisms and coronary artery disease: evidence based on an updated and cumulative meta-analysis
Wen-Qi Ma et al.
BIOSCIENCE REPORTS (2018)
The Global Epidemic of the Metabolic Syndrome
Mohammad G. Saklayen
CURRENT HYPERTENSION REPORTS (2018)
Adiponectin gene polymorphisms as a predictor for development of type 2 diabetes mellitus in Iraqi population
Majid Kadhum Hussain et al.
GENE (2018)
Association between ApoE polymorphism and hypertension: A meta-analysis of 28 studies including 5898 cases and 7518 controls
Jikang Shi et al.
GENE (2018)
Association of the APOA1 rs964184 SNP and serum lipid traits in the Chinese Maonan and Han populations
Ling Qiu et al.
LIPIDS IN HEALTH AND DISEASE (2018)
Genetic and microbiome influence on lipid metabolism and dyslipidemia
Maria Luisa Matey-Hernandez et al.
PHYSIOLOGICAL GENOMICS (2018)
Genetic association of ADIPOQ gene variants (-3971A>G and+276G>T) with obesity and metabolic syndrome in North Indian Punjabi population
Harjit Kaur et al.
PLOS ONE (2018)
Association between Genetic Variant of Apolipoprotein C3 and Incident Hypertension Stratified by Obesity and Physical Activity in Korea
Garam Jo et al.
NUTRIENTS (2018)
Candidate gene polymorphisms related to lipid metabolism in Asian Indians living in Durban, South Africa
Tanya Maistry et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2018)
Systematic Review and Meta-Analysis of Randomized, Controlled Trials on the Effect of Exercise on Serum Leptin and Adiponectin in Overweight and Obese Individuals
Na Yu et al.
HORMONE AND METABOLIC RESEARCH (2017)
Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review
C. S. Paththinige et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Associations of the APOB rs693 and rs17240441 polymorphisms with plasma APOB and lipid levels: a meta-analysis
Caiqin Niu et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis
William L. Holland et al.
MOLECULAR METABOLISM (2017)
Associations between polymorphisms of the ADIPOQ gene and hypertension risk: a systematic and meta-analysis
Weina Fan et al.
SCIENTIFIC REPORTS (2017)
The association between HDL particle concentration and incident metabolic syndrome in the multi-ethnic Dallas Heart Study
Preethi Mani et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)
ASSOCIATION OF THE APOLIPOPROTEIN A-I GENE POLYMORPHISMS WITH CARDIOVASCULAR DISEASE RISK FACTORS AND ATHEROGENIC INDICES IN PATIENTS FROM ASSAM, NORTHEAST INDIA
K. Bora et al.
BALKAN JOURNAL OF MEDICAL GENETICS (2017)
The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study
Thijs T. W. van Herpt et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Metabolic syndrome: genetic insights into disease pathogenesis
Maen D. Abou Ziki et al.
CURRENT OPINION IN LIPIDOLOGY (2016)
Weight-Loss Diets, Adiponectin, and Changes in Cardiometabolic Risk in the 2-Year POUNDS Lost Trial
Wenjie Ma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Familial defective apolipoprotein B-100: A review
Lars H. Andersen et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Type III Hyperlipoproteinemia: Still Worth Considering?
Conrad B. Blum
PROGRESS IN CARDIOVASCULAR DISEASES (2016)
Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome
Yanhua Wu et al.
PLOS ONE (2016)
The Distribution of Apolipoprotein E Gene Polymorphism and Apolipoprotein E Levels among Coronary Artery Patients Compared to Controls
Omer Atis et al.
EURASIAN JOURNAL OF MEDICINE (2016)
ATP-binding cassette transporter A1 (ABCA1) R219K (G1051A, rs2230806) polymorphism and serum high-density lipoprotein cholesterol levels in a large Japanese population: cross-sectional data from the Daiko Study
Junichiro Mokuno et al.
ENDOCRINE JOURNAL (2015)
The Apolipoprotein A1 polymorphisms were associated with decreased risk for metabolic syndrome in Koreans
Young Ree Kim et al.
GENES & GENOMICS (2015)
Genome-wide association study of triglyceride response to a high-fat meal among participants of the NHLBI Genetics of Lipid Lowering Drugs and Diet Network (GOLDN)
Mary K. Wojczynski et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Prevalence, associated factors and heritabilities of metabolic syndrome and its individual components in African Americans: the Jackson Heart Study
Rumana J. Khan et al.
BMJ OPEN (2015)
Relation between ADIPOQ Gene Polymorphisms and Type 2 Diabetes
Zhi-Peng Li et al.
GENES (2015)
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
Ron Do et al.
NATURE (2015)
Metabolic syndrome across Europe: Different clusters of risk factors
Angelo Scuteri et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)
Apolipoprotein B Is Related to Metabolic Syndrome Independently of Low Density Lipoprotein Cholesterol in Patients with Type 2 Diabetes
Younghyup Lim et al.
ENDOCRINOLOGY AND METABOLISM (2015)
Specific macrothrombocytopenia/hemolytic anemia associated with sitosterolemia
Zhaoyue Wang et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Genetic Evidence for a Normal-Weight Metabolically Obese Phenotype Linking Insulin Resistance, Hypertension, Coronary Artery Disease, and Type 2 Diabetes
Hanieh Yaghootkar et al.
DIABETES (2014)
Rs964184 (APOA5-A4-C3-A1) Is Related to Elevated Plasma Triglyceride Levels, but Not to an Increased Risk for Vascular Events in Patients with Clinically Manifest Vascular Disease
Anton P. van de Woestijne et al.
PLOS ONE (2014)
Genetics of metabolic syndrome
Alena Stancakova et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2014)
A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
Nicholas J. Timpson et al.
NATURE COMMUNICATIONS (2014)
Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population
Kandaswamy Ramya et al.
GENE (2013)
Identification and biochemical analysis of a novel APOB mutation that causes autosomal dominant hypercholesterolemia
Ellen R. A. Thomas et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2013)
The role of lecithin:cholesterol acyltransferase in the modulation of cardiometabolic risks - A clinical update and emerging insights from animal models
Dominic S. Ng
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Genome-Wide Screen for Metabolic Syndrome Susceptibility Loci Reveals Strong Lipid Gene Contribution But No Evidence for Common Genetic Basis for Clustering of Metabolic Syndrome Traits
Kati Kristiansson et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2012)
Association of the HindIII and S447X polymorphisms in LPL gene with hypertension and type 2 diabetes in Mexican families
Salvador Munoz-Barrios et al.
DISEASE MARKERS (2012)
Approach to the Patient with Extremely Low HDL-Cholesterol
Daniel J. Rader et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Population-Based Resequencing of APOA1 in 10,330 Individuals: Spectrum of Genetic Variation, Phenotype, and Comparison with Extreme Phenotype Approach
Christiane L. Haase et al.
PLOS GENETICS (2012)
A Bivariate Genome-Wide Approach to Metabolic Syndrome STAMPEED Consortium
Aldi T. Kraja et al.
DIABETES (2011)
Genetic variants in lipid metabolism are independently associated with multiple features of the metabolic syndrome
Cecile M. Povel et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Biological, clinical and population relevance of 95 loci for blood lipids
Tanya M. Teslovich et al.
NATURE (2010)
A Genome-Wide Association Study of the Metabolic Syndrome in Indian Asian Men
Delilah Zabaneh et al.
PLOS ONE (2010)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Association of Adiponectin Gene Polymorphisms With Type 2 Diabetes in an African American Population Enriched for Nephropathy
Meredith A. Bostrom et al.
DIABETES (2009)
The Linosa Study: Epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate
A. Bellia et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2009)
Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the Genetics of Lipid-Lowering Drugs and Diet Network study
Yongjun Liu et al.
PHARMACOGENETICS AND GENOMICS (2009)
Genetics of Metabolic Syndrome
Tisha Joy et al.
CURRENT DIABETES REPORTS (2008)
A German genome-wide linkage scan for type 2 diabetes supports the existence of a metabolic syndrome locus on chromosome 1p36.13 and a type 2 diabetes locus on chromosome 16p12.2
K. Hoffmann et al.
DIABETOLOGIA (2007)
Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the Diabetes Heart Study
Donald W. Bowden et al.
DIABETES (2006)
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
JC Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Interaction of the-308G/A promoter polymorphism of the tumor necrosis factor-alpha gene with single-nucleotide polymorphism 45 of the adiponectin gene: Effect on serum adiponectin concentrations in a Spanish population
JL Gonzalez-Sanchez et al.
CLINICAL CHEMISTRY (2006)
Genetic determinants of the metabolic syndrome
Rebecca L. Pollex et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2006)
Genetic contributors toward increased risk for ischemic heart disease
MA Nordlie et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study
HF Lin et al.
DIABETOLOGIA (2005)
Linkage of the metabolic syndrome to 1q23-q31 in hispanic families - The Insulin Resistance Atherosclerosis Study Family Study
CD Langefeld et al.
DIABETES (2004)
Associations between serum high-density lipoprotein cholesterol or apolipoprotein AI levels and common genetic variants of the ABCA1 gene in Japanese school-aged children
K Yamakawa-Kobayashi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
The S447X polymorphism of the lipoprotein lipase gene is associated with lipoprotein lipid and blood pressure levels in Chinese patients with essential hypertension
AP Liu et al.
JOURNAL OF HYPERTENSION (2004)
Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia
S Eichenbaum-Voline et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Genome-wide scan for type 2 diabetes loci in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25
MCY Ng et al.
DIABETES (2004)
Lipoprotein lipase gene polymorphisms and blood pressure levels in the northern Chinese han population
B Li et al.
HYPERTENSION RESEARCH (2004)
Hypoadiponectinemia is an independent risk factor for hypertension
Y Iwashima et al.
HYPERTENSION (2004)
A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia
JT Kao et al.
HUMAN MOLECULAR GENETICS (2003)
Coronary artery disease risk in familial combined - Hyperlipidemia and familial hypertriglyceridemia - A case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study
PN Hopkins et al.
CIRCULATION (2003)
Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians
F Vasseur et al.
HUMAN MOLECULAR GENETICS (2002)
Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review
JE Eichner et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH:: a clinical and molecular genetic analysis
M Arca et al.
LANCET (2002)
Apolipoprotein A-IMilano and apolipoprotein A-IParis exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I
JK Bielicki et al.
BIOCHEMISTRY (2002)
Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population
K Hara et al.
DIABETES (2002)
Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey
ES Ford et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans
R Arya et al.
DIABETES (2002)
The LPL S447X cSNP is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease
SM Clee et al.
CLINICAL GENETICS (2001)
Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study
SE Humphries et al.
LANCET (2001)
Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome
AH Kissebah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Lipoprotein lipase (C/G)447 polymorphism and blood pressure in the Stanislas Cohort
G Sass et al.
JOURNAL OF HYPERTENSION (2000)
Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischaemic heart disease in male smokers
PJ Talmud et al.
ATHEROSCLEROSIS (2000)